Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial
在初诊广泛期小细胞肺癌患者中，化疗前加用曲拉西利（Trilaciclib）和阿特珠单抗（atezolizumab）：一项多中心、随机、双盲、安慰剂对照的II期临床试验
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.33453
Daniel, Davey; Kuchava, Vladimer; Bondarenko, Igor; Ivashchuk, Oleksandr; Reddy, Sreekanth; Jaal, Jana; Kudaba, Iveta; Hart, Lowell; Matitashvili, Amiran; Pritchett, Yili; Morris, Shannon R; Sorrentino, Jessica A; Antal, Joyce M; Goldschmidt, Jerome
